PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-36.46%
Negative revenue growth while ENPH stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
223.64%
Gross profit growth of 223.64% while ENPH is zero. Bruce Berkowitz would see if minimal improvements could expand further.
-156.30%
Negative EBIT growth while ENPH is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-114.78%
Negative operating income growth while ENPH is at 0.00%. Joel Greenblatt would press for urgent turnaround measures.
1213.79%
Net income growth of 1213.79% while ENPH is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
737.25%
EPS growth of 737.25% while ENPH is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
737.25%
Diluted EPS growth of 737.25% while ENPH is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
0.26%
Share change of 0.26% while ENPH is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.07%
Diluted share change of 0.07% while ENPH is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
-79.62%
Negative OCF growth while ENPH is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-133.00%
Negative FCF growth while ENPH is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
15.16%
10Y CAGR of 15.16% while ENPH is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
15.16%
5Y CAGR of 15.16% while ENPH is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
89.04%
3Y CAGR of 89.04% while ENPH is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
103.91%
OCF/share CAGR of 103.91% while ENPH is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
103.91%
OCF/share CAGR of 103.91% while ENPH is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
249.97%
3Y OCF/share CAGR of 249.97% while ENPH is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
106.39%
10Y net income/share CAGR of 106.39% while ENPH is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
106.39%
Net income/share CAGR of 106.39% while ENPH is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
685.68%
3Y net income/share CAGR of 685.68% while ENPH is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
73.31%
Equity/share CAGR of 73.31% while ENPH is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
25.27%
AR growth of 25.27% while ENPH is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
24.66%
Inventory growth of 24.66% while ENPH is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
22.14%
Asset growth of 22.14% while ENPH is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
3.16%
BV/share growth of 3.16% while ENPH is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
43.80%
Debt growth of 43.80% while ENPH is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
21.36%
R&D growth of 21.36% while ENPH is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
4.35%
SG&A growth of 4.35% while ENPH is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.